Orchestra BioMed Holdings Inc (OBIO)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$5.08+7.17%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · OBIO
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 32.0 | 33.5 | 2.6 | 2.8 | 3.5 | — | — |
| Total Revenues | 32.0 | 33.5 | 2.6 | 2.8 | 3.5 | — | — |
| Cost of Revenues | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | — | — |
| Operating Expenses & Income | |||||||
| Selling, General & Admin | 26.6 | 26.9 | 23.9 | 20.3 | 14.0 | — | — |
| R&D Expenses | 63.2 | 58.2 | 42.8 | 33.8 | 21.9 | — | — |
| Other Operating Expenses, Total | (1.0) | (0.9) | 3.3 | 2.4 | (1.0) | — | — |
| Operating Income | (58.0) | (51.8) | (64.3) | (51.5) | (32.7) | (0.4) | — |
| Earnings from Continuing Operations | |||||||
| Interest & Investment Income | — | — | — | — | 0.3 | 0.0 | — |
| Net Income | |||||||
| Net Income | (59.0) | (52.7) | (61.0) | (49.1) | (33.6) | (0.4) | — |
| Per Share | |||||||
| Basic EPS | (0.93) | (1.11) | (1.66) | (1.48) | (2.24) | (0.02) | — |
| Diluted EPS | (0.93) | (1.11) | (1.66) | (1.48) | (2.24) | (0.02) | — |
| Revenue per Share | 0.50 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 63.8 | 47.7 | 36.8 | 33.2 | 15.0 | 20.5 | — |
| Diluted Weighted Avg Shares | 63.8 | 47.7 | 36.8 | 33.2 | 15.0 | 20.5 | — |
| Supplemental | |||||||
| EBITDA | — | (51.5) | (64.0) | (51.2) | (32.4) | — | — |
| EBIT | (58.0) | (51.8) | (64.3) | (51.5) | (32.7) | (0.4) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.